Concepedia

James C. Haber

JC

Statistics

Publications

7

Citations

224

H-Index

7

Active since

2004

Affiliations

Albany Molecular Research (United States)(Current)

CHDI Foundation

Evotec (United Kingdom)

Karolinska Institutet

Karolinska University Hospital

James C. Haber is an author at Albany Molecular Research (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2004–2022

7

Publications

7

Efficient Synthesis of 4-Aminoquinazoline and Thieno[3,2-<i>d</i>]pyrimidin-4-ylamine Derivatives by Microwave Irradiation

David Yoon, Ying Han, Todd M. Stark et al. · Organic Letters · 2004 · 73 citations

, , +13

Lead Optimization toward Proof-of-Concept Tools for Huntington’s Disease within a 4-(1<i>H</i>-Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors

John Wityak, Kevin F. McGee, Michael P. Conlon et al. · Journal of Medicinal Chemistry · 2015 · 38 citations

, , +17

[<sup>11</sup>C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins

Longbin Liu, Peter Johnson, Michael E. Prime et al. · Journal of Medicinal Chemistry · 2021 · 31 citations

, , +17

A facile N-arylation of acetanilides with arynes

James C. Haber, Michael A. Lynch, Stacey L. Spring et al. · Tetrahedron Letters · 2011 · 28 citations

, , +5

Design and Evaluation of [<sup>18</sup>F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates

Longbin Liu, Peter Johnson, Michael E. Prime et al. · Journal of Medicinal Chemistry · 2022 · 26 citations

, , +17

1–5 of 7